JP2014227380A5 - - Google Patents

Download PDF

Info

Publication number
JP2014227380A5
JP2014227380A5 JP2013108665A JP2013108665A JP2014227380A5 JP 2014227380 A5 JP2014227380 A5 JP 2014227380A5 JP 2013108665 A JP2013108665 A JP 2013108665A JP 2013108665 A JP2013108665 A JP 2013108665A JP 2014227380 A5 JP2014227380 A5 JP 2014227380A5
Authority
JP
Japan
Prior art keywords
butea
extract
sperba
lower alcohol
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013108665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014227380A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013108665A priority Critical patent/JP2014227380A/ja
Priority claimed from JP2013108665A external-priority patent/JP2014227380A/ja
Publication of JP2014227380A publication Critical patent/JP2014227380A/ja
Publication of JP2014227380A5 publication Critical patent/JP2014227380A5/ja
Pending legal-status Critical Current

Links

JP2013108665A 2013-05-23 2013-05-23 抗うつ剤 Pending JP2014227380A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013108665A JP2014227380A (ja) 2013-05-23 2013-05-23 抗うつ剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013108665A JP2014227380A (ja) 2013-05-23 2013-05-23 抗うつ剤

Publications (2)

Publication Number Publication Date
JP2014227380A JP2014227380A (ja) 2014-12-08
JP2014227380A5 true JP2014227380A5 (cg-RX-API-DMAC10.html) 2016-06-30

Family

ID=52127566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013108665A Pending JP2014227380A (ja) 2013-05-23 2013-05-23 抗うつ剤

Country Status (1)

Country Link
JP (1) JP2014227380A (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6890810B2 (ja) * 2018-01-11 2021-06-18 株式会社サン・クロレラ ＢＤＮＦ−ＴｒｋＢシグナル伝達系活性化剤及びＢＤＮＦ−ＴｒｋＢシグナル伝達系活性化用食品組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221690A1 (en) * 2006-02-28 2009-09-03 Council Of Scientific And Industrial Research Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof

Similar Documents

Publication Publication Date Title
JP2014515597A5 (cg-RX-API-DMAC10.html)
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
UY35492A (es) Compuestos novedosos
UY34811A (es) Compuestos y composiciones para inhibir la actividad de la abl1, abl2 y bcr-abl1
BR112015022191A8 (pt) compostos heteroarila e usos dos mesmos
JP2012106006A5 (cg-RX-API-DMAC10.html)
PH12015502546A1 (en) 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
JP2017537928A5 (cg-RX-API-DMAC10.html)
EP4327880A3 (en) Solid state form of ribociclib succinate
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
JP2015518492A5 (cg-RX-API-DMAC10.html)
JP2009108025A5 (cg-RX-API-DMAC10.html)
JP2017061576A5 (cg-RX-API-DMAC10.html)
MX389177B (es) Composiciones de azucares para la formacion de comprimidos mediante compresion directa.
IL281353A (en) Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containing gpr119 ligand as active ingredient
HK1221645A1 (zh) Vmat2的苯并喹啉抑制剂
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
HK1212978A1 (zh) 芥子酸的新型衍生物
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
JP2017014205A5 (cg-RX-API-DMAC10.html)
EA201690216A1 (ru) Фармацевтические композиции ранолазина и дронедарона
PL3019182T3 (pl) Kompozycja zawierająca oczyszczony wyciąg wyodrębniony z pseudolysimachion rotundum var. subintegrum zawierający dużą ilość składnika czynnego lub związki z niego wyodrębnione jako składnik czynny do zapobiegania lub leczenia przewlekłej obturacyjnej choroby płuc oraz jej zastosowania
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
JP2013227283A5 (cg-RX-API-DMAC10.html)